Trial Profile
"Tight glycaemic control" and the risk of hypoglycaemia: Is this different between multiple injections versus insulin pump therapy? A UK multi-centre, open randomised control trial.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Oct 2011
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary) ; Insulin glargine (Primary)
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions
- Acronyms DUK pump
- 06 Jul 2011 New trial record